Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus
Hande Aydemir, Hande Idil Tuz, Nihal Piskin, Guven Celebi, Canan Kulah, Furuzan Kokturk
Hande Aydemir, Hande Idil Tuz, Nihal Piskin, Guven Celebi, Department of Infectious Diseases and Clinical Microbiology, Zonguldak Bulent Ecevit University, Faculty of Medicine, Zonguldak 67100, Turkey
Canan Kulah, Department of Microbiology, Zonguldak Bulent Ecevit University, Faculty of Medicine, Zonguldak 67100, Turkey
Furuzan Kokturk, Department of Biostatistics, Zonguldak Bulent Ecevit University, Faculty of Medicine, Zonguldak 67100, Turkey
Author contributions: Aydemir H and Tuz HI contributed together to this work; Aydemir H, Piskin N and Celebi G designed research; Aydemir H, Tuz HI and Kulah C performed research; Kokturk F analyzed data; and Aydemir H wrote the paper.
Institutional review board statement: This study was approved by the ethics committee of Zonguldak Bulent Ecevit University Teaching and Research Hospital.
Informed consent statement: Patients were not required to give informed consent statement for this study due to the suggestion of ethical committee of our hospital. We did not use any personal data. The data which was used for this study is available from our hospital’s computer system. But written informed consent forms were taken for the agreement to treatment of pan-drug resistant Acinetobacter baumannii infections from patients or legal representatives.
Conflict-of-interest statement: All authors declare no conflicts of interest related to this article.
Data sharing statement: The datasets used and/or analyzed during this study available from the corresponding author on reasonable request.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Hande Aydemir, MD, Associate Professor, Department of Infectious Diseases and Clinical Microbiology, Zonguldak Bulent Ecevit University, Faculty of Medicine, Bülent Ecevit Üniversitesi Tıp fakültesi, Enfeksiyon hastalıkları A. D, Zonguldak 67100, Turkey. drhaydemir@yahoo.com
Telephone: +90-538-3712756 Fax: +90-372-2610264
Received: February 10, 2019
Peer-review started: February 12, 2019
First decision: April 18, 2019
Revised: April 24, 2019
Accepted: May 1, 2019
Article in press: May 1, 2019
Published online: May 26, 2019
